Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
45 participants
OBSERVATIONAL
2017-03-14
2018-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcome of Children Born After Pregnancy Denial
NCT03295123
Contraceptive Counselling: Impact on Awareness of the Risk of Unwanted Pregnancy and on the Appeal of Contraception
NCT05676762
Qualitative Exploratory Study Among Reunionese Women and Their Partners Who Have a Child With Trisomy 21
NCT04811534
The Midlands and North of England Stillbirth Study
NCT02025530
Support and Personalized Care in Alternative Midwifery Birth Units Versus Traditional Units in France: Effects on the Psychological Health of Couples and on the Health of the Mother and Child at the Age of 2 Years.
NCT06630741
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study is an non interventional case-control study. Socio-economic conditions, pregnancy care and prevention are screened to identified the major cause of foetal or new-born death in Reunion Island. These data are still lacking and will be useful to identify which public health actions that should be organized.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Foetal death
In-utero dead foetus weighting at least 500 g or 22-amenorrhea weeks old. In utero death means that death occurs during delivery or per partum
Foetal death
A midwife is in charge to interview the mother during the month following the lost of her infant.
New-born death
New-born dead during post-birth hospital stay and at least 23-amenorrhea weeks old.
New-born death
A midwife is in charge to interview the mother during the month following the lost of her infant.
Birth control for foetal death
Same gender child born, and alive, in the same hospital, and born on time (37-41 amenorrhea weeks old).
Birth control for foetal death
A midwife is in charge to interview the mother during her hospital stay
Birth control for new-born death
Same gender infant born, and alive, in the same hospital, and:
* for 23-amenorrhea weeks old new-born death: control new-born are born on time (37-41 amenorrhea weeks old).
* for 24 to 31-amenorrhea weeks old new-born death: control new-born are premature infant (24-31 amenorrhea weeks old), and are included when their hospital stay ends.
* for 32 and more-amenorrhea weeks old new-born death: control new-born are 32 and more-amenorrhea weeks old infant
Birth control for new-born death
A midwife is in charge to interview the mother during her hospital stay
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Foetal death
A midwife is in charge to interview the mother during the month following the lost of her infant.
New-born death
A midwife is in charge to interview the mother during the month following the lost of her infant.
Birth control for foetal death
A midwife is in charge to interview the mother during her hospital stay
Birth control for new-born death
A midwife is in charge to interview the mother during her hospital stay
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Control: premature (more than 23-amenorrhea weeks old) or mature new-born, alive when the leave the hospital
Exclusion Criteria
* second pregnancy during the study period
* case under forensic expertise
16 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de la Réunion
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Bernard GOUYON, Pr
Role: PRINCIPAL_INVESTIGATOR
Centre Hpospitalier Universitaire de La REUNION
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Reunion Island
Saint-Pierre, , Reunion
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016/CHU/08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.